Categories Earnings, LATEST, Technology

CyberArk’s stock gains after Q1 results beat estimates

CyberArk (NASDAQ: CYBR) reported first-quarter 2019 revenue and earnings that surpassed analysts’ expectations, sending the stock climbing by 5.8% in premarket hours on Tuesday.

Total revenue grew 34% year-over-year to $95.9 million. License revenue was $51.3 million, up 33% year-over-year while maintenance and professional services revenue rose 34% to $44.7 million.   

GAAP net income improved to $13.7 million, or $0.36 per share, from $6.4 million, or $0.18 per share, in the prior-year quarter. Adjusted net income was $21.5 million or $0.56 per share.

CEO Udi Mokady said, “Our results demonstrate that Privileged Access Security is the foundation of comprehensive cybersecurity programs. As the leader in the market, organizations of all sizes and industries are turning to CyberArk as a trusted advisor to secure digital transformation and cloud migration strategies. As we look at the remainder of 2019 and beyond, we are committed to delivering sustainable growth, strong profitability and continual innovation to secure privileged access across on-premises, hybrid and cloud environments.”

Total deferred revenue amounted to $171.1 million as of March 31, 2019, up 43% from the same period a year ago. At quarter-end, CyberArk had $509.7 million in cash, cash equivalents, marketable securities and short-term deposits.  

For the second quarter of 2019, CyberArk expects revenues to grow 24-26% year-over-year to a range of $96 million to $98 million. Adjusted EPS is expected to be $0.45-0.48.

For the full year of 2019, the company anticipates revenue growth of 21-22% to a range between $415 million and $419 million. Adjusted EPS is expected to be $2.10 to $2.16.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top